02/23/2021
https://congress.gov...
"Ms. Castor. You are right. And it is back on the Congress in a lot of ways. And I hope that they are listening and understand the huge cost if we do not address this."
"I think that is just part of the ongoing work of the agency and the Congress."
"Well, clearly this has really been overlooked, and my sense is that it rests more with the FDA than the Congress."
"I want to commend the authors of the legislation for addressing something that evidently has been overlooked for decades."